OrthoPediatrics (NASDAQ: KIDS) 10% holder plans 700K-share sale

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP (KIDS) had a large shareholder, Squadron Capital, LLC, file a notice of proposed sale of common stock under Rule 144. Squadron, identified as a 10% stockholder, plans to sell up to 700,000 shares of KIDS common stock through broker Stifel Nicolaus & Company Inc.

The filing lists an aggregate market value of approximately $18,361,000 for these shares and states there are 26,109,788 shares of common stock outstanding. Squadron notes that the shares to be sold represent about 10% of its holdings and that the sale is intended to provide additional capital for its other portfolio businesses.

The shares being sold were originally acquired from the issuer on 09/20/2022 through a purchase of 1,525,000 common shares, with consideration described as cash plus forgiveness of debt, with payment dated 08/15/2022. The notice is dated 08/24/2026.

Key Figures

Shares to be sold: 700,000 shares Aggregate market value of shares to be sold: $18,361,000 Shares outstanding: 26,109,788 shares +5 more

8 metrics

Shares to be sold 700,000 shares Common stock to be sold by Squadron Capital, LLC under Rule 144

Aggregate market value of shares to be sold $18,361,000 Market value of the 700,000 common shares subject to the Form 144 notice

Shares outstanding 26,109,788 shares Outstanding common stock of ORTHOPEDIATRICS CORP

Shares acquired from issuer 1,525,000 shares Common shares acquired by Squadron Capital on 09/20/2022

Portion of Squadron holdings represented by sale Approximately 10% Remarks describing the 700,000 shares relative to Squadron’s holdings

Date of acquisition 09/20/2022 Acquisition date for the 1,525,000 common shares

Date of payment 08/15/2022 Payment date for acquisition consideration (cash plus forgiveness of debt)

Date of Notice 08/24/2026 Date on which the Form 144 notice was filed

Key Terms

Rule 144, 10% Stockholder, forgiveness of debt, aggregate market value, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10% Stockholder financial

"10% Stockholder 144: Securities Information"

forgiveness of debt financial

"08/15/2022 | Cash plus forgiveness of debt"

aggregate market value financial

"700000 | 18361000 | 26109788"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Securities To Be Sold regulatory

"144: Securities To Be Sold Common Stock | 09/20/2022"

FAQ

What does the Form 144 filing for ORTHOPEDIATRICS CORP (KIDS) disclose?

It discloses that Squadron Capital, LLC, a 10% stockholder, has filed to sell up to 700,000 shares of KIDS common stock under Rule 144 through broker Stifel Nicolaus & Company Inc., with an aggregate market value of about $18,361,000.

How large is the planned share sale by Squadron Capital in KIDS stock?

Squadron Capital plans to sell up to 700,000 shares of ORTHOPEDIATRICS CORP common stock, with the filing indicating an aggregate market value of about $18,361,000 for these shares.

What portion of Squadron Capital’s KIDS holdings does the 700,000-share sale represent?

The remarks state that the 700,000 shares to be sold represent approximately 10% of Squadron Capital’s holdings of ORTHOPEDIATRICS CORP’s outstanding common stock.

Why is Squadron Capital selling KIDS (ORTHOPEDIATRICS CORP) shares?

The remarks explain that the proposed sale is being undertaken to provide additional capital for Squadron Capital’s other portfolio businesses.

When and how did Squadron Capital acquire the KIDS shares referenced in the Form 144?

The filing shows that Squadron Capital acquired 1,525,000 KIDS common shares on 09/20/2022 from the issuer, with consideration described as cash plus forgiveness of debt and a payment date of 08/15/2022.

How many ORTHOPEDIATRICS CORP (KIDS) shares are outstanding according to the Form 144?

The securities information section lists 26,109,788 shares of ORTHOPEDIATRICS CORP common stock outstanding.

What is the date of the Form 144 notice filed for ORTHOPEDIATRICS CORP (KIDS)?

The Date of Notice on the Form 144 is 08/24/2026, and it is signed by David Pelizzon, President for Squadron Capital, LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:33 PM Accepted by SEC EDGAR 08/24/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001719228
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Orthopediatrics Corp.
SEC File Number
Address of Issuer	2850 Frontier Drive Warsaw INDIANA 46582
Phone	5742686379
Name of Person for Whose Account the Securities are To Be Sold	Squadron Capital, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	700000	18361000	26109788	08/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/20/2022	Purchase of Common shares	Issuer			1525000	08/15/2022	Cash plus forgiveness of debt

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The number of shares to be sold by the Reporting Person represents approximately 10% of its holdings of the Issuers outstanding common stock. The proposed sale is being undertaken to provide additional capital for the Reporting Persons other portfolio businesses.
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Pelizzon, President
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)